# LexaGene Life Sciences CF Investors, Inc. — Form C (Regulation Crowdfunding)

LexaGene Life Sciences CF Investors, Inc. of DALLAS, TX filed a Form C (Regulation Crowdfunding) with the SEC on 2023-10-31. Target raise $26K, up to $5.0M. Offered through DEALMAKER SECURITIES LLC.

## Offering

- Filed: 2023-10-31
- Form: C
- Accession: 0001104659-23-112915
- Target amount: $26K
- Maximum amount: $5.0M
- Security type: Common Stock
- Securities offered: 25,750
- Price: $1.0300
- Deadline: 2024-10-31
- Funding portal / intermediary: DEALMAKER SECURITIES LLC
- Intermediary file number: 008-70756
- Intermediary CRD: 315324

## Issuer

- CIK: 0001998226
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2023-08-18
- Address: 3811 TURTLE CREEK BLVD., STE 875, DALLAS, TX, 75219
- Employees: 0

## Financials (as filed)

- Total assets (most recent): $65K
- Cash (most recent): $1K
- Net income (most recent): $11K

## People (2)

| Name | Role | Location |
| --- | --- | --- |
| Curtis R. Boisfontaine | Manager | DALLAS, TX |
| David K. Ronck | Chief Financial Officer and Director | DALLAS, TX |

## More

- [CIK 1998226 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1998226&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formc/0001104659-23-112915.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.